Xiu Xiu Pharmaceutical Group is a large-scale modern private enterprise integrating scientific research, production and marketing. The group headquarters is located in Changchun and the marketing headquarters is located in Beijing.

Xiu Xiu Pharmaceutical Group was founded in May 1995 by Chairman Xiu Laigui. It integrates the scientific research, production and marketing of patent medicines, chemical pharmaceuticals, and biopharmaceuticals, pharmaceutical chain operations, and standard cultivation of traditional Chinese medicinal materials. A large modern private pharmaceutical enterprise.

Xiu Xiu Pharmaceutical has two head offices, three national-level well-known trademarks "Xiu Xiu, Tong Yao and Star Shu", and 14 sales platforms. Since 2000, Xiu Xiu Pharmaceutical has maintained sales for 10 consecutive years. It ranked first in the comprehensive ranking of pharmaceutical companies in Jilin Province in 2004. Since 2004, it has ranked first in the profit ranking of traditional Chinese medicine companies in the country. Its sales and profits rank among the top ten in the Chinese pharmaceutical industry.

Extended information

Correction of excessive pharmaceutical industry incident

Event history

Due to suspected excessive chromium, the State Food and Drug Administration in 2012 An emergency notice was issued on April 16, 2016, requiring the suspension of sales and use of 13 medicinal hollow capsule products. These include Antelope Cold Capsules produced by Amended Pharmaceuticals.

After the "industrial gelatin production of medicinal capsules" incident was exposed, the official website of Xiu Xiu Pharmaceutical was hacked for a time, and the page was changed to six words starting with "Have you used my rotten shoes to make capsules?" Line characters.

Wang Zhiguang, senior vice president of Xiu Xiu Pharmaceutical, responded that the production date of the batch number submitted by CCTV for inspection was before the implementation of the new national standard, and the chromium content was not included in the testing scope before.

Incident handling

Four days after CCTV exposed the "problematic capsules", Xiu Xiu Pharmaceutical released on its official website on April 19, 2012, "About the handling process of Antelope cold capsules suspected of exceeding the standard of chromium" "Notice", stating that 199 Antelope cold capsules suspected of containing excessive chromium have been recalled, and apologized to the public through the website.

The announcement stated that the Antelope Cold Capsule production line of Xiuxi Pharmaceutical has been suspended for self-inspection. At the same time, the safety team has carried out internal quality inspection, procurement, circulation and other aspects of inspection and responsibility tracing, and actively cooperated with the national drug regulatory agency Inspection of capsule products.

Xiu Xiu Pharmaceutical also stated that it plans to invest 300 million yuan to build its own capsule production enterprise in the next two years. They deeply apologize for the inconvenience this incident has caused to consumers, customers, the government and the media. He also stated that in future actions, the public will be informed of follow-up progress in a timely manner.

Baidu Encyclopedia-Xiu Xiu Pharmaceutical Group